Andrikopoulou, A.; Theofanakis, C.; Markellos, C.; Kaparelou, M.; Koutsoukos, K.; Apostolidou, K.; Thomakos, N.; Haidopoulos, D.; Rodolakis, A.; Dimopoulos, M.-A.;
et al. Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer. Cancers 2023, 15, 3519.
https://doi.org/10.3390/cancers15133519
AMA Style
Andrikopoulou A, Theofanakis C, Markellos C, Kaparelou M, Koutsoukos K, Apostolidou K, Thomakos N, Haidopoulos D, Rodolakis A, Dimopoulos M-A,
et al. Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer. Cancers. 2023; 15(13):3519.
https://doi.org/10.3390/cancers15133519
Chicago/Turabian Style
Andrikopoulou, Angeliki, Charalampos Theofanakis, Christos Markellos, Maria Kaparelou, Konstantinos Koutsoukos, Kleoniki Apostolidou, Nikolaos Thomakos, Dimitrios Haidopoulos, Alexandros Rodolakis, Meletios-Athanasios Dimopoulos,
and et al. 2023. "Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer" Cancers 15, no. 13: 3519.
https://doi.org/10.3390/cancers15133519
APA Style
Andrikopoulou, A., Theofanakis, C., Markellos, C., Kaparelou, M., Koutsoukos, K., Apostolidou, K., Thomakos, N., Haidopoulos, D., Rodolakis, A., Dimopoulos, M.-A., Zagouri, F., & Liontos, M.
(2023). Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer. Cancers, 15(13), 3519.
https://doi.org/10.3390/cancers15133519
